Handelsbanken Fonder’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $253K | Buy |
96,000
+3,700
| +4% | +$9.75K | ﹤0.01% | 1462 |
|
|
2025
Q1 | $278K | Hold |
92,300
| – | – | ﹤0.01% | 1428 |
|
|
2024
Q4 | $236K | Buy |
92,300
+38,400
| +71% | +$98.2K | ﹤0.01% | 1495 |
|
|
2024
Q3 | $201K | Hold |
53,900
| – | – | ﹤0.01% | 1493 |
|
|
2024
Q2 | $341K | Buy |
+53,900
| New | +$341K | ﹤0.01% | 1331 |
|
|
2022
Q2 | – | Sell |
-26,900
| Closed | -$151K | – | 1651 |
|
|
2022
Q1 | $151K | Hold |
26,900
| – | – | ﹤0.01% | 1662 |
|
|
2021
Q4 | $164K | Buy |
26,900
+10,900
| +68% | +$66.5K | ﹤0.01% | 1724 |
|
|
2021
Q3 | $156K | Hold |
16,000
| – | – | ﹤0.01% | 1664 |
|
|
2021
Q2 | $228K | Buy |
+16,000
| New | +$228K | ﹤0.01% | 1681 |
|